BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2019
View Archived Issues
Prion protein with gain of function found
Read More
Impaired ATM function linked to worse rheumatoid arthritis
Read More
MAC-545496, a potent inhibitor that attenuates virulence and reverses antibiotic resistance in MRSA
Read More
AXS-12 achieves primary endpoint in CONCERT phase II study in narcolepsy
Read More
Biogen reports phase II data from LILAC study of BIIB-059
Read More
Early data from first patient in phase Ib/II study of leronlimab in CCR5-poisitive mTNBC
Read More
Positive interim data reported from ongoing phase IIa combination portion of CANFOUR study
Read More
Positive topline data from part 1 of adaptive phase III RENEW study of reproxalap
Read More
Preliminary phase II results for PTG-300 in transfusion-dependent beta-thalassemia
Read More
StemoniX and Atomwise create joint venture that will initially target Rett syndrome
Read More
P. falciparum-induced malaria model created in immunocompromised juvenile mice
Read More
89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC
Read More
Results form phase II study of galunisertib in MDS
Read More
Study shows how individual brain cell types contribute to AD
Read More
Vivace Therapeutics patents transcriptional coactivator YAP1/TEAD interaction inhibitors
Read More
FDA accepts IND for phase I trial of SKL-24741 for epilepsy
Read More
Sichuan Kelun-Biotech Biopharmaceutical presents ARG1-targeting PROTACs
Read More
New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals
Read More
Nuvation Bio discovers PARP inhibitors
Read More
Abide Therapeutics identifies new monoglyceride lipase inhibitors
Read More
Phase II trial of CNSA-001 in PKU meets primary and secondary endpoints
Read More
Xenikos initiates phase III study of T-Guard for steroid-refractory GvHD
Read More
Healthy volunteer safety data reported from phase IIb study of EB-01 in allergic contact dermatitis
Read More
Calmodulinopathy model used to study development of arrythmias
Read More
Tiziana begins phase I trial of oral foralumab in healthy volunteers
Read More